Cannabicyclol (CBL) is a non-psychoactive cannabinoid present in cannabis. CBL is a cannabinoid that develops when CBC (cannabichromene) degrades due to UV light and oxidation. The study of this minor cannabinoid has been gradual, and little is known about its characteristics and medicinal potential.
Scientists are still discovering the qualities and benefits of cannabicyclol, as they do with many minor cannabinoids. CBL has not yet been subjected to medicinal testing. As research on minor cannabinoids expands, we may better grasp cannabicyclol’s distinctive properties in the future.